1 / 41

Asian Menopause Survey March 2007

linaeve
Download Presentation

Asian Menopause Survey March 2007

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

    1. Page.1 Asian Menopause Survey March 2007 Hans Rekers VP Medical Affairs NV Organon Asian Menopause/SWB Survey was conducted from December 2005 to March 2006. I am happy to share with you this study that interviewed 1,000 women of Asia. Lot has been known on women elsewhere, but not really on Asian women.Asian Menopause/SWB Survey was conducted from December 2005 to March 2006. I am happy to share with you this study that interviewed 1,000 women of Asia. Lot has been known on women elsewhere, but not really on Asian women.

    2. Page.2 Objectives To provide : Current insights in women’s thoughts and feelings about menopause and HRT: Their views Their perceptions Their concerns Their fears Their beliefs Their experiences Their needs Why the survey? The ongoing debate about the risks and benefits of HRT has led to confusion and anxiety among both physicians and postmenopausal women Therefore the major aim of this study is: Why the survey? The ongoing debate about the risks and benefits of HRT has led to confusion and anxiety among both physicians and postmenopausal women Therefore the major aim of this study is: Why the survey? The ongoing debate about the risks and benefits of HRT has led to confusion and anxiety among both physicians and postmenopausal women Therefore the major aim of this study is: Why the survey? The ongoing debate about the risks and benefits of HRT has led to confusion and anxiety among both physicians and postmenopausal women Therefore the major aim of this study is:

    3. Page.3

    4. Page.4 Research design & methodology

    5. Page.5 Survey on Menopause in ASIA PACIFIC

    6. Page.6 Questionnaire design Demographic profile Attitudes, Interests and Opinions regarding to: Menopause Breast Sexual well-being

    7. Page.7 Findings Menopause Breast Sexual well-being

    8. Page.8 Almost 1 in 2 women are afftected by the menopause. This is not as many as in Europe but many enough to justify being addressed.Almost 1 in 2 women are afftected by the menopause. This is not as many as in Europe but many enough to justify being addressed.

    9. Page.9 1. Sleeplessness is the most mentioned symptom with the highest impact on the women. 2. While 64% of European women rated the symptoms as severe, only approx. 10% Asian women did so. In Asia symptoms tend to be mild in 50% of the case. 1. Sleeplessness is the most mentioned symptom with the highest impact on the women. 2. While 64% of European women rated the symptoms as severe, only approx. 10% Asian women did so. In Asia symptoms tend to be mild in 50% of the case.

    10. Page.10 Reasons to seek treatment in Asia

    11. Page.11 Reasons to seek treatment in Europe Unlike in Asia where sleeplessness & hot flushes are the reasons for seeking treatment, in Europe hot flushes are by far the biggest reason for seeking treatment.Unlike in Asia where sleeplessness & hot flushes are the reasons for seeking treatment, in Europe hot flushes are by far the biggest reason for seeking treatment.

    12. Page.12 Usage of treatments in Europe

    13. Page.13 Usage of treatments in Asian

    14. Page.14 HRT usage in Asia by country/regions

    15. Page.15 General feeling about HRT

    16. Page.16 55% compares fairly well to 61% European women’s association of breast cancer risk with the HRT. 55% compares fairly well to 61% European women’s association of breast cancer risk with the HRT.

    17. Page.17

    18. Page.18

    19. Page.19 Findings Menopause Breast Sexual well-being

    20. Page.20

    21. Page.21

    22. Page.22 Perceived risk factor for developing breast cancer (Europe)

    23. Page.23

    24. Page.24 55% compares fairly well to 61% European women’s association of breast cancer risk with the HRT. 55% compares fairly well to 61% European women’s association of breast cancer risk with the HRT.

    25. Page.25 Perceived differences between various kinds of HRT (Europe)

    26. Page.26 Women were asked if they perceive differences between various kinds of HRT. Only 32% said there are differences between therapies, Hardly any women (6%) knew there are differences regarding their major concern: the effects on the breast, though overall 59% of women (vs. 87% in Europe) replied they are well informed on the HRT.Women were asked if they perceive differences between various kinds of HRT. Only 32% said there are differences between therapies, Hardly any women (6%) knew there are differences regarding their major concern: the effects on the breast, though overall 59% of women (vs. 87% in Europe) replied they are well informed on the HRT.

    27. Page.27 Findings Menopause Breast Sexual well-being

    28. Page.28 Reduced sexual functioning

    29. Page.29 Discomfort during sex

    30. Page.30 Reduced sexual interest has a negative impact

    31. Page.31 Reasons for not seeking treatment

    32. Page.32

    33. Page.33

    34. Page.34

    35. Page.35 Menopause and ageing perceived as main reasons for reduced sexual functioning

    36. Page.36 More than half the women don’t discuss problems with partners, only 6% with their doctors

    37. Page.37 With improved sexual functioning I would enjoy life more

    38. Page.38 75% women would talk about it if doctors bring it up

    39. Page.39 Summary and conclusions Sleeplessness and hot flushes are most common reason for seeking treatment for Asian women HRT use is much lower in Asian than in European women Breast cancer risk (and other perceived AEs) major hurdle for acceptance of hormone treatment Perceived efficacy differences between HRT options, no awareness in differences in breast (cancer) effects

    40. Page.40 Summary and conclusions Most women experience reduction in libido / sexual functioning This affects their femininity, QoL and self esteem Most women uninformed about treatment options and/or unwilling to seek or take treatment 6% discuss symptoms with their doctor, 75% willing to discuss in doctor initiates 61% would enjoy life more if sexual functioning improved

    41. Page.41 Menopausal womens’ needs

More Related